NCT07039513View on ClinicalTrials.gov

EVOLUTION OF D-DIMER AS A MARKER OF BLEEDING RISK ON ECMO

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

January 1, 2027

Study Completion Date

February 1, 2027

Conditions
ECMOMplementation of a Veno-venous VV or Veno-arterial VAINTENSIVE CARE
Interventions
OTHER

Blood sampling collection

Collection of an additional of 2.7mL citrate tube of blood for a D-dimer dosage.

Trial Locations (1)

67098

Service de Médecine Intensive - Réanimation Nouvel Hôpital Civil, Strasbourg

All Listed Sponsors
lead

University Hospital, Strasbourg, France

OTHER

NCT07039513 - EVOLUTION OF D-DIMER AS A MARKER OF BLEEDING RISK ON ECMO | Biotech Hunter | Biotech Hunter